New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2014
07:37 EDTTHORThoratec price target raised to $39 from $37 at Canaccord
Canaccord raised its price target on Thoratec to $39 from $37 following the company's proposed acquisition of Apica. The firm sees double digit earnings potential for Thoratec given its VAD prospects and ability to target the fast growing acute MCS space and keeps its Buy rating on the stock.
News For THOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for THOR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use